Brief: Cara Therapeutics Reports First Quarter 2023 Financial Results
15/05/2023 21:30
Cara Therapeutics Inc CARA.O :
* CARA THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
* CARA THERAPEUTICS - QTRLY TOTAL REVENUE OF $6.2 MILLION
* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AT MARCH
31
TOTALED $123.4 MILLION
* QTRLY LOSS PER SHARE $0.49
* Q1 EARNINGS PER SHARE VIEW $-0.52 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX2MY424
Further company coverage: CARA.O
Recent news on Tvardi Therapeutics
See all newsTvardi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tvardi Therapeutics Q2 net loss slightly lower estimates
Brief: Tvardi Therapeutics Inc Q2 Net Income USD -6.5 Million Vs. IBES Estimate USD -6.54 Million
Tvardi Therapeutics, Inc. expected to post a loss of 70 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:50 PM